Now showing items 1-2 of 2
Development of Novel Cancer Immunotherapeutics Utilizing Cell-Targeting Peptides
Cancer immunotherapy is an emerging treatment option that offers high tumor specificity and efficacy. Immune therapies for cancer can be divided into two main types: active and passive. Active therapy strives to achieve a ...
Development of an αᵥβ₆-Binding Peptide for In Vivo Applications: Modulation of Serum Stability and Biodistribution
Targeted delivery of imaging and therapeutic agents to tumors improves detection, characterization, and treatment of many types of cancers. Peptides are capable of efficient and selective delivery of a variety of cargoes ...